Epstein Secrets

Sec of Defense for Counternarcotics and Global Threats. *Adam Weiss''—co-CEO, Scout Capital. * *Katharine Weymouth"— Publisher, Washington Post.* *Michael Wolf'—CEO, Activate. fmr President and COO, MN Networks. Fmr Prtnr, McKinsey. Former Senior Partner, Booz Allen & Hamilton. *Paul Wolpes— Director, Center of

tharine Weymouth"— Publisher, Washington Post.* *Michael Wolf'—CEO, Activate. fmr President and COO, MN Network

cerdoti*— CEO, BrightRoll. Board: ReTargeter. 'Amy Salzhauer *— CEO, Ignition. 'Cami Samuels'— General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. 'Ken Sawyer'-- CEO, Saints Ventures (manages over $1 billion in capital). Selected to Forbes Mid

c of Defense for Counternarcotics and Global Threats. *Adam Weiss' s— co-CEO, Scout Capital. * *Katharine Weymouth"— Publisher, Washington Post.* *Michael Wolf'—CEO, Activate. fmr President and COO, MN Networks. Fmr Prtnr, McKinsey. Former Senior Partner, Booz Allen & Hamilton. *Paul Wolpes— Director, Center of

tharine Weymouth"— Publisher, Washington Post.* *Michael Wolf'—CEO, Activate. fmr President and COO, MN Network

cerdoti*— CEO, BrightRoll. Board: ReTargeter. 'Amy Salzhauer *— CEO, Ignition. 'Cami Samuels'— General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. 'Ken Sawyer'-- CEO, Saints Ventures (manages over $1 billion in capital). Selected to Forbes Mid

ec of Defense for Counternarcotics and Global Threats. *Adam Weiss**— co-CEO, Scout Capital. * *Katharine Weymouth**— Publisher, Washington Post.* *Michael Wolf*— CEO, Activate. fmr President and COO, MTV Networks. Fmr Prtnr, McKinsey. Former Senior Partner, Booz Allen & Hamilton. *Paul Wolpe*— Director, Cen

erdoti*— CEO, BrightRoll. Board: ReTargeter. * Amy Salzhauer *— CEO, Ignition. *Cami Samuels*— General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera HOUSE_OVERSIGHT_017587 --- PAGE BREAK --- Biopharmaceuticals, Semprae Laboratories. *Ken Sawyer*-- CEO, Saints Ventures (manages over $1

Asst. Sec of Defense for Counternarcotics and Global Threats. Adam Weiss — co-CEO, Scout Capital. Katharine Weymouth — Publisher, Washington Post. Michael Wolf — CEO, Activate. fmr President and COO, MTV Networks. Fmr Prtnr, McKinsey. Former Senior Partner, Booz Allen & Hamilton. Paul Wolpe — Director, Cent

Sacerdoti — CEO, BrightRoll. Board: ReTargeter. Amy Salzhauer — CEO, Ignition. Cami Samuels — General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. Ken Sawyer -- CEO, Saints Ventures (manages over $1 billion in capital). Selected to Forties Mida

and Global Threats. *Adam Weiss**- co-CEO, Scout Capital. * *Katharine Weymouth**— Publisher, Washington Post.* EFTA_R1_00460089 EFTA01974891 *Michael Wolf'— CEO, Activate. fmr President and COO, MTV Networks. Fmr Prtnr, McKinsey. Former Senior Partner, Booz Allen & Hamilton. *Paul Wolpe*— Director, Cen

ReTargeter. *Amy Salzhauer *— CEO, Ignition. EFTA_R1_00460088 EFTA01974890 *Cami Samuels*— General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. *Ken Sawyer*-- CEO, Saints Ventures (manages over $1 billion in capital). Selected to Forbes Mi

ec of Defense for Countcrnarcotics and Global Threats. *Adam Weiss**- co-CEO, Scout Capital. * *Katharine Weymouth**— Publisher, Washington Post* *Michael Wolf"— CEO, Activate. finr President and COO, MTV Networks. Fmr Prtnr, McKinsey. Former Senior Partner, Booz Allen & Hamilton. *Paul Wolpe*— Director, C

cerdoti*— CEO, BrightRoll. Board: ReTargeter. *Amy Salzhauer *— CEO, Ignition. *Cami Samuels"— General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. *Ken Sawyers-- CEO, Saints Ventures (manages over $1 billion in capital). Selected to Forbes Mi

Sacerdoti — CEO, BrightRoll. Board: ReTargeter. Amy Salzhauer - CEO, Ignition. Cami Samuels - General Partner, Versant Ventures. Boards: Achaogen, APT Pharmaceuticals, Kythera Biopharmaceuticals, Semprae Laboratories. Ken Sawyer -- CEO, Saints Ventures (manages over $1 billion in capital). Selected to Forbes Midas

Asst. Sec of Defense for Counternarcotics and Global Threats. Adam Weiss — co-CEO, Scout Capital. Katharine Weymouth - Publisher, Washington Post. Michael Wolf — CEO, Activate. fmr President and COO, MTV Networks. Fmr Prtnr, McKinsey. Former Senior Partner, Booz Allen & Hamilton. Paul Wolpe — Director, Cente